Season’s greetings to you and your families as we reflect upon SGO’s many accomplishments during the year 2012. This year our membership exceeded 1,600 members, all of whom reflect the depth and breadth of the field of gynecologic oncology.
This is a critical time for our subspecialty and we need to have our professional Society play a major role in demonstrating our value in delivering the complex surgical and medical care women with gynecologic cancer often require. Our Society’s members need to do this by remaining well educated about our subspecialty and by having access to tools that will ensure we are providing the highest quality and most cost effective gynecologic cancer care in the economic and political environment in which we live.
I am especially proud of the decision we made this year to establish the Foundation for Gynecologic Oncology, which was created to properly address the significant changes that are occurring throughout our national health care system, our subspecialty and individual practices. Within our Foundation is the newly developed Outcomes Research Institute. The Institute will play an important role in conducting research, generating quantifiable data and promoting awareness that will demonstrate improved quality and patient outcomes in gynecologic oncology. We will send SGO members a brief survey later this month to help us identify research priorities. Your participation is critical to the success of this important endeavor.
As you know we are in the midst of an endowment campaign to support the efforts of our Foundation and Society. If you have not done so already, please consider making a pledge to ensure our future success.
SGO and the leaders of this organization are taking the steps needed to see that quality care for our patients remains first and foremost and that any investments of time or money we ask of our members will be well worth the effort. On behalf of the board and staff of SGO, I would like to thank you for your support of SGO and the women you serve on a daily basis as subspecialists in the field of gynecologic oncology.
Ronald D. Alvarez, MD